- Home
- PAXS vs ASPI Comparison
PAXS vs ASPI Comparison
Compare PAXS & ASPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PAXS | ASPI |
|---|---|---|
| Founded | N/A | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Major Chemicals |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 673.8M | 783.1M |
| IPO Year | 2021 | 2022 |
Fundamental Metrics
Financial Performance| Metric | PAXS | ASPI |
|---|---|---|
| Price | $14.67 | $5.64 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | 167.2K | ★ 5.0M |
| Earning Date | 01-01-0001 | 04-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $23,849,000.00 |
| Revenue This Year | N/A | $68.41 |
| Revenue Next Year | N/A | $126.69 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 475.48 |
| 52 Week Low | $13.74 | $3.92 |
| 52 Week High | $16.56 | $14.49 |
Technical Indicators
Market Signals| Indicator | PAXS | ASPI |
|---|---|---|
| Relative Strength Index (RSI) | 68.57 | 40.33 |
| Support Level | $14.30 | $5.16 |
| Resistance Level | $14.86 | $6.02 |
| Average True Range (ATR) | 0.17 | 0.64 |
| MACD | 0.07 | -0.16 |
| Stochastic Oscillator | 93.90 | 4.39 |
Price Performance
Historical ComparisonAbout PAXS PIMCO Access Income Fund of Beneficial Interest
PIMCO Access Income Fund is a non-diversified, limited-term, closed-end management investment company. The fund seeks current income as an objective and capital appreciation as a secondary objective. It achieves the investment objectives by utilizing a dynamic asset allocation among multiple sectors in the public and private credit markets, including corporate debt.
About ASPI ASP Isotopes Inc.
ASP Isotopes Inc is a materials company focused on producing and commercializing enriched isotopes for the nuclear medicine, healthcare, green energy, and quantum computing industries. Currently, the company has three operating segments: (i) nuclear fuels, (ii) specialist isotopes and related services, and (iii) construction services. Using proprietary technology-the Aerodynamic Separation Process (ASP)-the company enriches isotopes in South Africa, targeting high-value, low-volume markets to reduce reliance on foreign supply chains. Geographically, the company operates in South Africa, Hong Kong and United States generating key revenue from the Hong Kong region.